Euronext N.V.

ENX.PA·Paris·Financial Services
Compare
167.20+1.40 (+0.84%)today
At close: Oct 16, 5:35 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close165.80
Open166.10
Day range165.10167.30
52-week range110.00169.50
Off day high−0.06%
Off 52-week high−1.36%
Volume280.35K
Avg. volume (3M)173.83K
Market cap—
EPS (TTM)6.91
Forward P/E18.18
P/E ratio (TTM)24.20
Dividend yield1.91% (3.18)
Beta (5Y)0.86
Shares outstanding—
Short interest—
Earnings dateNov 5, 2026
Analyst target168.41
Profit margin35.91%

Against its peers

Compare in full ›
ENX.PA 0388.HK ICE LSEG.L CBOE S68.SI
Market cap — 473.49B 90.70B 42.11B 32.89B 22.49B
P/E (TTM) 24.2 24.0 22.8 31.9 24.6 33.3
Forward P/E 18.2 23.2 18.2 16.0 20.7 25.2
Price/book 3.7 7.8 3.1 2.3 5.9 9.5
Dividend yield 1.91% 3.97% 1.29% 1.82% 1.12% 2.08%
1-year change +31.90% −11.86% +4.04% +0.65% +28.57% +24.72%
Today +0.84% +0.86% +1.99% +0.97% +2.24% +0.53%

The closest companies by business and industry (Financial Data & Stock Exchanges). Prices may be delayed up to 15 min.

Latest news

All ENX.PA news ›
Euromoney·Positive

The world’s best venue for investor education 2026: Euronext

Euromoney The world’s best venue for investor education 2026: Euronext Euronext treats investor education as part of its market infrastructure, not just an add-on. Through Euronext Academy, its training arm, it teaches about 1,500…

MarketScreener·

WE.CONNECT: Relative Strength Chart - Stock Euronext Paris

Compare WE.CONNECT with the company of your choice via a Relative Strength chart. Real-time ALWEC price, Euronext Paris stock exchange Relative Strength Chart WE.CONNECT Electronic Equipment & Parts All financial news and data tailored to…

MarketScreener·

GenSight Biologics S.A. Stock (SIGHT) - Quote Euronext Paris

GenSight Biologics S.A. specializes in the research and development of gene therapies for the treatment of mitochondrial diseases and eye neurodegeneratives. At the end of 2025, the company had a portfolio of 2 products, including 1 in…

MarketScreener·

Bigben Interactive: Relative Strength Chart - Stock Euronext Paris

Compare Bigben Interactive with the company of your choice via a Relative Strength chart. Real-time BIG price, Euronext Paris stock exchange Relative Strength Chart Bigben Interactive Toys & Juvenile Products All financial news and data…

MarketScreener·

Eiffage S.A.: Relative Strength Chart - Stock Euronext Paris

Compare Eiffage S.A. with the company of your choice via a Relative Strength chart. Real-time FGRMC price, Euronext Paris stock exchange Relative Strength Chart Eiffage S.A. All financial news and data tailored to specific country editions

MarketScreener·

The Navigator Company, S.A. Stock (NVG) - Quote Euronext Lisbonne

The Navigator Company, S.A. is a leading European producer of printing paper. Net sales break down by activity as follows: - production of printing paper (61.5%): 1,297 Kt sold in 2025 (Navigator, Inacopia, Discovery, MultiOffice, Inacopia…

MarketScreener·Positive

Getlink SE: Relative Strength Chart - Stock Euronext Paris

Compare Getlink SE with the company of your choice via a Relative Strength chart. Real-time GET price, Euronext Paris stock exchange Relative Strength Chart Getlink SE Highways & Rail Tracks All financial news and data tailored to specific…

From articles in the 4Search news index.

In the news

534mentions in 30 days
534with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.